Related content

Development and Validation of a Clinical Risk Score Predicting the No-Reflow Phenomenon in Patients Treated with Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

By  

Cardiology, Vol. 124, Iss. 3, 2013-03 ,pp. : 153-160

Karger

Access to resources Recommend Favorite

The white blood cell count is an independent predictor of no-reflow and mortality following acute myocardial infarction in the coronary interventional era

By Kojima Sunao   Sakamoto Tomohiro   Ishihara Masaharu   Kimura Kazuo   Miyazaki Shunichi   Tei Chuwa   Hiraoka Hisatoyo   Sonoda Masahiro   Tsuchihashi Kazufumi   Yamagishi Masakazu   Inoue Takeshi   Asada Yujiro   Ikeda Yoshihiko   Shirai Mutsunori   Ogawa Hisao  

Annals of Medicine, Vol. 36, Iss. 2, 2004-04 ,pp. : 153-160

Informa Healthcare

Access to resources Recommend Favorite

Aspirin ‘Resistance': Impact on No-Reflow, Platelet and Inflammatory Biomarkers in Diabetics after ST-Segment Elevation Myocardial Infarction

By  

Cardiology, Vol. 131, Iss. 1, 2015-04 ,pp. : 41-50

Karger

Access to resources Recommend Favorite

Clinical Features and Outcome of Coronary Artery Aneurysm in Patients with Acute Myocardial Infarction Undergoing a Primary Percutaneous Coronary Intervention

By  

Cardiology, Vol. 98, Iss. 3, 2002-11 ,pp. : 132-140

Karger

Access to resources Recommend Favorite

Acute myocardial infarction in patients with syncope

By  

Canadian Journal of Emergency Medicine, Vol. 11, Iss. 2, 2009-03 ,pp. : 156-160

Cambridge University Press

Access to resources Recommend Favorite